VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2014

Jul 17, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2014-07-15

Reporting Person: Chodakewitz Jeffrey (SVP GMDA, CMO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-07-15	Stock Option	$96.87	A	27500	Acquired	2024-07-14	Common Stock (27500)	Direct

Footnotes

F1: The option vests in 16 quarterly installments from 07/15/2014.